Assessment of patients with hereditary transthyretin amyloidosis–understanding the impact of management and disease progression

I Conceição, T Coelho, C Rapezzi, Y Parman, L Obici… - Amyloid, 2019 - Taylor & Francis
Timely diagnosis of hereditary variant transthyretin (ATTRv) amyloidosis is critical for
appropriate treatment and optimal outcomes. Significant differences are seen between …
被引用次数：59 相关文章
[PDF] archive.org

[PDF][PDF] Assessment of patients with hereditary transthyretin amyloidosis–understanding the impact of management and disease progression

I Conceição, T Coelho, C Rapezzi, Y Parman… - AMYLOID, 2019 - scholar.archive.org
Timely diagnosis of hereditary variant transthyretin (ATTRv) amyloidosis is critical for
appropriate treatment and optimal outcomes. Significant differences are seen between …

Assessment of patients with hereditary transthyretin amyloidosis-understanding the impact of management and disease progression.

I Conceição, T Coelho, C Rapezzi… - … of Experimental and …, 2019 - europepmc.org
Timely diagnosis of hereditary variant transthyretin (ATTRv) amyloidosis is critical for
appropriate treatment and optimal outcomes. Significant differences are seen between …

[引用][C] Assessment of patients with hereditary transthyretin amyloidosis–understanding the impact of management and disease progression

I Conceição, T Coelho, C Rapezzi, Y Parman, L Obici… - Amyloid, 2019 - cir.nii.ac.jp
Assessment of patients with hereditary transthyretin amyloidosis – understanding the impact
of management and disease progression | CiNii Research CiNii 国立情報学研究所 学術情報 …
[PDF] openaccessrepository.it

[PDF][PDF] Assessment of patients with hereditary transthyretin amyloidosis–understanding the impact of management and disease progression

I Conceição, T Coelho, C Rapezzi, Y Parman, L Obici… - 2019 - openaccessrepository.it
Timely diagnosis of hereditary variant transthyretin (ATTRv) amyloidosis is critical for
appropriate treatment and optimal outcomes. Significant differences are seen between …

Assessment of patients with hereditary transthyretin amyloidosis-understanding the impact of management and disease progression

I Conceicao, T Coelho, C Rapezzi… - AMYLOID …, 2019 - avesis.istanbul.edu.tr
Timely diagnosis of hereditary variant transthyretin (ATTRv) amyloidosis is critical for
appropriate treatment and optimal outcomes. Significant differences are seen between …

Assessment of patients with hereditary transthyretin amyloidosis-understanding the impact of management and disease progression

I Conceição, T Coelho, C Rapezzi… - … : the official journal …, 2019 - pubmed.ncbi.nlm.nih.gov
Timely diagnosis of hereditary variant transthyretin (ATTRv) amyloidosis is critical for
appropriate treatment and optimal outcomes. Significant differences are seen between …

Assessment of patients with hereditary transthyretin amyloidosis–understanding the impact of management and disease progression.

I Conceição, T Coelho, C Rapezzi, Y Parman… - Amyloid, 2019 - search.ebscohost.com
Timely diagnosis of hereditary variant transthyretin (ATTRv) amyloidosis is critical for
appropriate treatment and optimal outcomes. Significant differences are seen between …

Assessment of patients with hereditary transthyretin amyloidosis: understanding the impact of management and disease progression

T Coelho, C Rapezzi, Y Parman, L Obici, L Galán… - Amyloid, 2019 - repositorio.ul.pt
Timely diagnosis of hereditary variant transthyretin (ATTRv) amyloidosis is critical for
appropriate treatment and optimal outcomes. Significant differences are seen between …
[PDF] unife.it

[PDF][PDF] Assessment of patients with hereditary transthyretin amyloidosis–understanding the impact of management and disease progression

I Conceição, T Coelho, C Rapezzi, Y Parman, L Obici… - AMYLOID, 2019 - iris.unife.it
Timely diagnosis of hereditary variant transthyretin (ATTRv) amyloidosis is critical for
appropriate treatment and optimal outcomes. Significant differences are seen between …